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1. Exercise Referral Evaluation Research 
1.1. Evaluation Overview and Methods  
The following evaluation research examined the data for patients who were referred by health 
professionals for supervised exercise.  
The purpose was to examine data for patients attending Lincolnshire’s Exercise Referral (ER) 
Programme over a 12 month period.  
The analysis was in response to questions that had been identified by Lincolnshire Sport and Public 
Health Lincolnshire. This was to examine any changes in the New Zealand Physical Activity 
Questionnaire (NZPAQ) and the EQ-5D-3L (health related quality of life measure) scores in relation 
to the following: 
 Gender. 
 Reason for referral.  
 Body Mass Index (BMI).  
 Postcode (area of deprivation). 
Relevant data were accessed via Lincolnshire Sport’s parachute system and were analysed via the 
calculation of statistics (i.e. percentages; means ± standard deviations; binary logistic regression).  
The data spanned a period of 12 months and included patients in the database who started a 12-
week ER programme between September through to November 2013, and attended the first (week 
1), second (week 12) and none or more of the following two visits (6 and 12 months).  
There were 935 eligible patients with 776 (82.9%) patients completing week 1 of the NZPAQ (61.8% 
female and 38.2% male) and 780 (83.4%) completing week 1 of the EQ-5D-3L (62% female and 38% 
male). The number of completions varied across each question for both surveys, and all responses 
that were provided have been analysed.     
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2. Key Findings 
2.1. General Responses 
It was of interest to provide an overall analysis of the number of responses to both questionnaires 
and the general patterns that had been observed in the data. 
In review of the NZPAQ, the number of patients’ recorded data varied considerably between each 
question and the different time points (as shown in table 2.1a below). The questionnaire has three 
types of questions: 0-7 day response (questions 1, 3, 5 and 7); open question on how much time 
spent performing physical activity (questions 2, 4 and 6), and; 5-option closed question (question 
8). The open questions on time spent active resulted in fewer answers entered into the database, 
partly as directed by the NZPAQ to skip these questions. The number of responses decreased over 
the 12 months as fewer people attended however there was a proportionally higher completion 
rate noted for questions 2, 4 and 6. This is encouraging as these questions were only completed if 
the patient had answered the previous questions (i.e. 1, 3 and 5) with a value greater than 0, 
identifying on how many days they had been active.  
Table 2.1a Number of patients completing NZPAQ 
Question Week 1 Week 12 6 months 12 months 
1 (brisk walk: 0-7 days) 776 679 214 59 
2 (brisk walk: mins) 401 550 185 47 
3 (moderate activity: 0-7 days) 780 678 214 59 
4 (moderate activity: mins) 315 606 181 44 
5 (vigorous activity: 0-7 days) 775 666 208 58 
6 (vigorous activity: mins) 121 241 76 19 
7 (frequency all activity: 0-7 
days) 773 670 210 57 
8 (state of change: 1-5 score) 785 681 215 59 
Overall the data showed an increase in the mean scores for each question between week 1 and 12 
months (table 2.1b). This would suggest that patients were increasing the days and time spent 
active. These values were found to be significant for question 1 generally improving over time, and 
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for question 5 initially improving at week 12 but then reducing at 6 and 12 months (see appendix 1 
table 1a for P values). For questions 2 and 4 there were no or few significant differences over time 
(see appendix 1 table 1a for P values). Of the eight questions only two continued to increase 
through the time points, questions 1 and 8. This indicated that the number of days spent briskly 
walking had continued to increase over a period of 12 months and how the patient classified their 
regular physical activity levels had increased. 
Table 2.1b NZPAQ mean scores 
Question Week 1 Week 12 6 months 12 months 
1 (brisk walk: 0-7 days) 1.85 2.90 3.15 3.37 
2 (brisk walk: mins) 43.27 41.03 43.96 48.23 
3 (moderate activity: 0-7 days) 1.23 2.95 2.80 2.14 
4 (moderate activity: mins) 63.01 52.88 50.88 68.82 
5 (vigorous activity: 0-7 days) 0.31 1.37 0.87 0.71 
6 (vigorous activity: mins) 39.18 39.49 31.88 54.58 
7 (frequency all activity: 0-7 
days) 2.18 4.35 4.68 4.07 
8 (state of change: 1-5 score) 2.68 3.67 3.70 4.00 
(higher scores better; see appendix 1 table 1a for P values) 
In review of the EQ-5D-3L the number of patients responding showed only minor variation between 
each question but larger changes between time points. As with the NZPAQ however it was unclear 
as to why there was any variation in the number of patients completing each of the 6 questions at 
each time point (as shown in table 2.1c below). 
The number of patients completing the questionnaire declined for all questions over the 12 month 
period. It was noted however that 781 patients completed question 6 in week 1 in comparison to 
slightly lower numbers being recorded for the remaining five questions. As previously stated it is 
unclear as to why this is the case other than patients did not fully complete the questionnaire or 
imputing errors into the parachute system. 
Table 2.1c Number of patients completing EQ-5D-3L 
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Question Week 1 Week 12 6 months 12 months 
1 (mobility) 780 677 215 59 
2 (selfcare) 778 675 215 59 
3 (activity) 777 673 215 59 
4 (pain/ 
discomfort) 774 677 214 57 
5 (anxiety/ 
depression) 777 676 215 59 
6 (health/ 
status) 781 679 215 59 
The mean data showed a number of changes for each question between week 1 and 12 months 
(table 2.1d). Only questions 2 and 6 presented a higher mean at 12 months than what was originally 
recorded at week 1. Question 2 represented patients’ perspectives on their self-care so an increase 
in this figure would have been seen as a decline in their ability to care for themselves, however this 
increase was found not to be significant (see appendix 1 table 1b for P values). Question 6 asked 
patients to reflect on their state of health. An increase in this figure was positive, indicating that 
patients felt that their state of health had improved. This increase between week 1 and, week 12, 6 
months and 12 months were all found to be significant (see appendix 1 table 1b for P values).   
For the remaining questions (1, 3, 4 and 5) all of the 12 month values were found to be statistically 
lower than those means calculated at week 1. These decreases can all be viewed as positive as 
these would indicate improvements in how patients viewed their ease of mobility, problems 
experienced with usual activities, pain and feelings of anxiety. None of these decreases between 
week 1 and 12 months however were found to be significant (see appendix 1 table 1b for P values).  
As with the NZPAQ data, changes in means throughout the time points were observed with 
questions 1 and 4 (Mobility and Pain) showing the greatest variation. Questions 2, 3, 5 and 6 were 
more consistent with changes in means, either progressively increasing or decreasing, as previously 
highlighted. 
Table 2.1d EQ-5D-3L mean scores  
Question Week 1 Week 12 6 months 12 months 
1 (mobility) 1.31 1.26 1.32 1.27 
   
7 
2 (selfcare) 1.06 1.07 1.07 1.08 
3 (activity) 1.37 1.28 1.27 1.25 
4 (pain/ 
discomfort) 1.59 1.49 1.48 1.51 
5 (anxiety/ 
depression) 1.35 1.29 1.26 1.20 
6 (health/ 
status) 53.62 65.23 67.93 71.85 
(1-5 lower scores better; 6 higher score better; see appendix 1 table 1b for P values) 
2.2. Gender 
When comparing NZPAQ data for males and females the changes in means presented similar 
patterns to those shown in the overall data. For all the duration questions (questions 2, 4 and 6) for 
both sexes’ scores there were none or few statistical differences between time points (see 
appendix 2 table 2a for P values). Nevertheless, there was a general trend for the duration of 
physical activity to increase over time for both sexes. 
Table 2.2a Female mean scores for NZPAQ 
Question Week 1 Week 12 6 months 12 months 
1 (brisk walk: 0-7 days) 1.86 2.92 3.05 3.55 
2 (brisk walk: mins) 41.65 39.55 42.88 49.26 
3 (moderate activity: 0-7 days) 1.12 2.69 2.67 2.03 
4 (moderate activity: mins) 56.50 50.78 45.60 72.92 
5 (vigorous activity: 0-7 days) 0.24 1.36 0.76 0.48 
6 (vigorous activity: mins) 31.16 36.73 34.92 42.70 
7 (frequency all activity: 0-7 days) 2.07 4.30 4.73 4.94 
8 (state of change: 1-5 score) 2.63 3.61 3.56 4.09 
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(higher scores better; see appendix 2 table 2a for P values) 
Question 4 required patients to reflect on time spent moderately active. For both sexes, each 
question’s mean across the time points followed similar patterns, however women presented a 
higher mean at 12 months in comparison to week 1, with men’s scores lower at 12 months. 
Changes though were not significant (see appendix 2 table 2a and 2b for P values).  
Changes in days active (questions 1, 3, 5 and 7) for both sexes generally showed significant 
increases in comparison to week 1 over time. Although there was some fluctuation in activity days 
from 12 weeks through 6 and 12 months, these changes for both sexes were generally not 
significant. 
Table 2.2b Male mean scores for NZPAQ 
Question Week 1 Week 12 6 months 12 months 
1 (brisk walk: 0-7 days) 1.85 2.87 3.30 3.15 
2 (brisk walk: mins) 45.83 43.55 45.58 46.85 
3 (moderate activity: 0-7 days) 1.42 3.37 3.01 2.27 
4 (moderate activity: mins) 73.05 56.27 59.24 63.42 
5 (vigorous activity: 0-7 days) 0.42 1.38 1.04 1.00 
6 (vigorous activity: mins) 49.13 43.72 28.68 67.78 
7 (frequency all activity: 0-7 days) 2.37 4.44 4.59 2.96 
8 (state of change: 1-5 score) 2.75 3.75 3.91 3.88 
(higher scores better; see appendix 2 table 2b for P values) 
Completion of the EQ-5D-3L also generated a range of responses when comparing males and 
females. For all but one question (question 2) the comparison of the mean between week 1 and 12 
months generated the same outcomes. There were few changes from week 1 to 12 months, except 
for question 1 for males that significantly increased/worsened (mobility) and question 6 for females 
that significantly increased/improved (state of health). In addition, for question 5 (anxiety) the 12 
month mean was significantly lower than that recorded at week 1 for females, but not for males 
(see appendix 2 table 2c and 2d for P values).  
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Table 2.2c Male mean scores for EQ-5D-3L 
Question Week 1 Week 12 6 months 12 months 
1 (mobility) 1.30 1.24 1.27 1.19 
2 (selfcare) 1.07 1.07 1.07 1.12 
3 (activity) 1.35 1.28 1.23 1.23 
4 (pain/ 
discomfort) 1.52 1.41 1.39 1.38 
5 (anxiety/ 
depression) 1.31 1.27 1.29 1.15 
6 (health/ 
status) 54.71 66.21 68.65 71.73 
(1-5 lower scores better; 6 higher score better; see appendix 2 table 2c for P values) 
For question 1 (mobility) the male mean was significantly lower at 12 months in comparison to 
week 1, whereas the female there was no significant difference (see appendix 2 table 2c and 2d for 
P values). 
Differences were also observed between the other data collection points (12 weeks and 6 months). 
Of each of the questions, only question 6 which required patients to reflect on the state of their 
health, exhibited a consistent increase in mean throughout the data collection points for both 
males (significant for 1-12 week and 1 week – 6 months) and females (significant for 1-12 weeks, 1 
week – 6 months, 1 week – 12 months) (see appendix 2 table 2c and 2d for P values).   
Table 2.2d Female mean scores for EQ-5D-3L 
Question Week 1 Week 12 6 months 12 months 
1 (mobility) 1.31 1.27 1.35 1.33 
2 (selfcare) 1.05 1.06 1.07 1.06 
3 (activity) 1.38 1.29 1.29 1.27 
4 (pain/ 
discomfort) 1.63 1.54 1.53 1.61 
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5 (anxiety/ 
depression) 1.37 1.30 1.24 1.24 
6 (health/ 
status) 52.95 64.62 67.49 71.94 
(1-5 lower scores better; 6 higher score better; see appendix 2 table 2d for P values) 
2.3. Reason for Referral 
It was interesting to observe whether the reason a patient was referred related to the results of the 
two questionnaires. For those patients referred for obesity (approximately 50% of respondents) 
only two questions were significantly different at 12 months in comparison to week 1 values: 
question 1 and 8, both of which increased (improved). For question 4 the mean was 15.8 lower, but 
this was not significantly proved. 
Other reasons for referral (e.g. musculoskeletal, mental health, pulmonary condition) generally 
showed significant improvements for days active (i.e. questions 1, 3, 5 and 7) but no significant 
difference for time active (i.e. questions 2, 4 and 6) (see appendix 3 table 3a and 3b for P values). 
Table 2.3a Patients referred for obesity mean NZPAQ scores 
Question Week 1 Week 12 6 months 12 months 
1 (brisk walk: 0-7 days) 1.76 2.80 3.00 2.91 
2 (brisk walk: mins) 40.71 39.33 42.55 44.58 
3 (moderate activity: 0-7 days) 1.14 2.89 2.77 1.61 
4 (moderate activity: mins) 68.27 53.18 47.54 52.47 
5 (vigorous activity: 0-7 days) 0.32 1.58 0.98 0.61 
6 (vigorous activity: mins) 38.72 43.03 29.76 52.50 
7 (frequency all activity: 0-7 days) 2.06 3.84 4.05 2.48 
8 (state of change: 1-5 score) 2.56 3.59 3.49 3.74 
(higher scores better; see appendix 3 table 3a for P values) 
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What was interesting to note was the changes observed between 6 and 12 months. For those 
patients referred for obesity, questions 1, 3, 5 and 7 the mean decreased at 12 months in 
comparison to 6 months. In contrast, for questions 2, 4, 6 and 8 the means all increased over the 
same period of time. This suggested that although the number of days spent active had decreased, 
the time spent active had increased and their state of change had improved. These changes were 
all however not significant. For those referred for other reasons the data indicated similar patterns, 
and although not significant for days active (i.e. questions 3, 5 and 7) the improvement was 
significantly better for duration of activity (i.e. questions 4 and 6 between 12 weeks and 12 months) 
(see appendix 3 table 3a and 3b for P values). 
Table 2.3b Patients referred for other reasons mean NZPAQ scores 
Question Week 1 Week 12 6 months 12 months 
1 (brisk walk: 0-7 days) 1.96 3.01 3.34 3.67 
2 (brisk walk: mins) 45.79 42.67 45.65 50.71 
3 (moderate activity: 0-7 days) 1.33 3.01 2.85 2.47 
4 (moderate activity: mins) 58.35 52.57 55.09 79.11 
5 (vigorous activity: 0-7 days) 0.29 1.15 0.71 0.77 
6 (vigorous activity: mins) 39.70 35.47 35.13 56.09 
7 (frequency all activity: 0-7 days) 2.32 4.87 5.49 5.15 
8 (state of change: 1-5 score) 2.80 3.75 3.97 4.17 
(higher scores better; see appendix 3 table 3b for P values) 
When comparing the reasons for referral against results of the EQ-5D-3L, for those patients 
referred for obesity only question 4 (pain/discomfort) significantly improved from week 1 to 12 
weeks, and question 6 (health status) improved from week 1 to 12 weeks, 6 months and 12 
months. Similar to other variables, after 12 weeks there were no significant changes. 
Table 2.3c EQ-5D-3L mean scores for patients referred for obesity 
Question Week 1 Week 12 6 months 12 months 
1 (mobility) 1.30 1.26 1.36 1.39 
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2 (selfcare) 1.07 1.06 1.09 1.13 
3 (activity) 1.32 1.26 1.25 1.30 
4 (pain/ 
discomfort) 1.56 1.45 1.51 1.68 
5 (anxiety/ 
depression) 1.32 1.26 1.29 1.30 
6 (health/ 
status) 53.03 64.60 66.22 71.78 
(1-5 lower scores better; 6 higher score better; see appendix 3 table 3c for P values) 
For those referred for other reasons the mean scores differed in comparison, specifically questions 
3, 4, 5 and 6 which all significantly improved from week 1 to 12 months. This indicated 
improvements in usual activity, pain, anxiety and health status (see appendix 3 table 3d for P 
values). For anxiety and health status there were also continued significant improvements from 
week 12 to 12 months.  
Table 2.3d EQ-5D-3L mean scores for patients referred for other reasons 
Question Week 1 Week 12 6 months 12 months 
1 (mobility) 1.32 1.26 1.27 1.19 
2 (selfcare) 1.05 1.07 1.04 1.06 
3 (activity) 1.42 1.30 1.28 1.22 
4 (pain/ 
discomfort) 1.61 1.54 1.43 1.40 
5 (anxiety/ 
depression) 1.37 1.31 1.23 1.14 
6 (health/ 
status) 54.23 65.86 70.17 71.89 
(1-5 lower scores better; 6 higher score better; see appendix 3 table 3d for P values) 
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2.4. BMI 
It was useful to examine both questionnaire responses in relation to a patient’s BMI score. Through 
appropriate analysis (binary logistic regression) it would be possible to determine if one particular 
variable was significant in predicting a change in patient’s BMI. NZPAQ days active questions (i.e. 1, 
3, 5, 7 and 8; as they had higher response rates) and all EQ-5D-3L questions, using only the week 1 
responses that had the largest sample size.  
Following analysis it was identified that anxiety (EQ-5d-3L question 5) was the only variable that 
was significant in predicting BMI change of >.33kg/m2 (.33kg/m2 was the approximate median BMI 
change from the data). This was most apparent for those with low levels of anxiety, where an odds 
score above 1 indicated the change was more likely to happen (as shown in table 2.4a). This 
highlights that for those patients demonstrating lower levels of anxiety they would be more likely 
to change and improve their BMI.  
Table 2.4a Odds of anxiety predicting BMI change 
Variable Odds Significance (p) 
Low Anxiety 1.33 0.004 
Medium Anxiety 0.77 0.002 
High Anxiety 0.27 0.005 
 
2.5. Deprivation 
For the NZPAQ, there was little consistency in patterns between improvements or worsening scores 
in comparing high and low deprivation scores. Similarly, there was little consistency in the pattern 
of statistical differences across the 8 questions between the high and low deprivation (see Table 
2.5a). 
Table 2.5a NZPAQ scores mean difference between high (6-10) minus low (1-5) deprivation scores 
(negative are low deprivation scores are less; positive are high deprivation scores are greater) 
Question Week 1 Week 12 6 months 12 months Better for 
high group 
Better for 
low group 
1 (days) 0.28 0.30 0.65 1.02 High (+) Low (-) 
2 (mins) -3.06 -6.35 6.75 23.62 High (+) Low (-) 
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3 (days) 0.00 -0.34 0.00 0.98 High (+) Low (-) 
4 (mins) -3.93 12.75 9.06 19.19 High (+) Low (-) 
5 (days) -0.17 -1.10 -0.23 0.04 High (+) Low (-) 
6 (mins) -7.27 1.25 12.71 12.43 High (+) Low (-) 
7 (days) 0.39 -0.24 -0.47 0.87 High (+) Low (-) 
8 (1-5) -0.01 0.05 0.45 1.02 High (+) Low (-) 
(better scores indicated in right hand columns; see appendix 3 table 4a for P values) 
In contrast, for the EQ-5D-3L, there was high consistency in results between high and low 
deprivation scores. For all 6 questions at all time points the high deprivation score (i.e. least 
deprived) revealed better scores than the low deprivation score (indicated by negative numbers for 
questions 1-5 and positive values for question 6; table 2.5b). This was significant at several time 
points, with anxiety being statistically significant between the majority of time points. 
Table 2.5b EQ-5D-3L scores mean difference between high (6-10) minus low (1-5) deprivation 
scores (negative are low deprivation scores are less; positive are high deprivation scores are 
greater) 
Question Week 1 Week 12 6 months 12 months Better for 
high group 
Better for 
low group 
1 (mobility) -0.06 -0.10 -0.21 -0.30 Low (-) High (+) 
2 (selfcare) -0.02 -0.02 -0.03 -0.09 Low (-) High (+) 
3 (activity) -0.09 -0.10 -0.08 -0.20 Low (-) High (+) 
4 (pain/ 
discomfort) -0.04 -0.09 -0.29 -0.44 
Low (-) High (+) 
5 (anxiety/ 
depression) -0.16 -0.10 -0.14 -0.24 
Low (-) High (+) 
6 (health/ 
status) 4.31 3.99 1.20 6.97 
High (+) Low (-) 
(better scores indicated in right hand columns; see appendix 4 table 4b for P values) 
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3. Summary 
The purpose of this evaluation was to examine the data compiled by Lincolnshire’s ER programmes 
in relation to clearly defined questions about NZPAQ and EQ-5D-3L changes. The primary findings in 
relation to each question can be summarised as the following:  
 NZPAQ mean scores for days active, but not activity duration, were generally significantly 
improved at 12 weeks, 6 months and 12 months in comparison to week 1 for both males 
and females.  
 EQ-5D-3L also showed improved scores for most questions at week 12 for both males and 
females, but fewer improved scores at 6 months and 12 months. Females showed greater 
improvements than males. 
 NZPAQ mean scores for those patients referred for obesity significantly increased from 
week 1 to 12 weeks and 6 months, but fewer improvements to 12 months (only question 1 
and 8). Patients referred for other reasons (i.e. non-obesity) showed greater improvements 
at 12 months, particularly in the number of days active.  
 EQ-5D-3L mean scores for those patients referred for obesity showed some improvement in 
health status (question 6), but most other variables showed no change. In contrast, patients 
referred for other reasons showed greater improvements that lasted up to 12 months, and 
included improvements from 12 weeks to 6 and 12 months particularly for health status. 
 Anxiety (EQ-5d-3L question 5), and no other EQ-5d-3L or NZPAQ questions, was the only 
variable to significantly contribute to predicting the likelihood of BMI changing by >.33kg/m2 
(approximately the median BMI change from week 1 to week 12). Those with low levels of 
anxiety had the highest likelihood of improving their BMI.   
 Deprivation was poorly distinguished by the NZPAQ, whereas the EQ-5D-3L had high 
consistency in distinguishing between high and low deprivation scores. For all 6 questions at 
all time points the high deprivation score (i.e. least deprived) revealed better EQ-5D-3L 
scores than the low deprivation score. 
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4. Appendices 
Appendix 1 
Table 1a NZPAQ mean score P values (shaded indicates significant) 
Question 1-12 weeks  1 week – 6 
months 
1 week – 12 
months 
12 weeks – 
6 months 
12 weeks – 
12 months 
6 months – 
12 months 
1 (days) 0.000 0.000 0.000 0.448 0.000 0.000 
2 (mins) 0.109 0.525 0.425 0.285 0.933 0.577 
3 (days) 0.000 0.000 0.000 0.060 0.630 0.814 
4 (mins) 0.305 0.512 0.908 0.024 0.493 0.216 
5 (days) 0.000 0.000 0.003 0.024 0.000 0.000 
6 (mins) 0.003 0.002 0.477 0.024 0.547 0.793 
7 (days) 0.000 0.000 0.013 0.749 0.459 0.435 
8 (1-5) 0.000 0.000 0.000 0.816 0.175 0.035 
Table 1b EQ-5D-3L mean scores P values (shaded indicates significant) 
Question 1-12 weeks  1 week – 6 
months 
1 week – 12 
months 
12 weeks – 
6 months 
12 weeks – 
12 months 
6 months – 
12 months 
1 (mobility) 0.000 0.183 0.167 0.103 1.000 1.000 
2 (selfcare) 0.842 1.000 0.182 0.706 1.000 1.000 
3 (activity) 0.000 0.000 0.109 0.848 0.568 0.660 
4 (pain/ 
discomfort) 0.000 0.002 0.103 0.790 0.289 1.000 
5 (anxiety/ 
depression) 0.001 0.158 0.135 0.613 0.182 0.743 
6 (health/ 
status) 0.000 0.000 0.001 0.719 0.750 0.226 
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Appendix 2 
Table 2a Female mean score P values for NZPAQ (shaded indicates significant) 
Question 1-12 weeks  1 week – 6 
months 
1 week – 12 
months 
12 weeks – 
6 months 
12 weeks – 
12 months 
6 months – 
12 months 
1 (days) 0.000 0.000 0.012 0.416 0.126 0.469 
2 (mins) 0.195 0.786 0.776 0.858 0.966 0.450 
3 (days) 0.000 0.000 0.008 0.203 0.366 0.256 
4 (mins) 0.306 0.942 0.353 0.013 0.647 0.538 
5 (days) 0.020 0.000 0.025 0.158 0.301 0.450 
6 (mins) 0.801 0.561 1.000 0.796 0.226 0.374 
7 (days) 0.000 0.000 0.029 0.375 0.201 0.822 
8 (1-5) 0.000 0.000 0.000 0.365 0.051 0.090 
Table 2.b Male mean score P values for NZPAQ (shaded indicates significant) 
Question 1-12 weeks  1 week – 6 
months 
1 week – 12 
months 
12 weeks – 
6 months 
12 weeks – 
12 months 
6 months – 
12 months 
1 (days) 0.000 0.000 0.110 0.853 0.484 1.000 
2 (mins) 0.347 0.568 0.160 0.139 0.813 0.576 
3 (days) 0.000 0.000 0.001 0.167 0.796 0.207 
4 (mins) 0.662 0.462 0.437 0.947 0.589 0.065 
5 (days) 0.005 0.001 0.039 0.180 0.479 0.767 
6 (mins) 0.965 0.565 0.529 0.426 0.031 0.136 
7 (days) 0.000 0.000 0.198 0.631 0.090 0.269 
8 (1-5) 0.000 0.000 0.002 0.465 0.907 0.205 
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Table 2c Male mean score P values for EQ-5D-3L (shaded indicates significant) 
Question 1-12 weeks  1 week – 6 
months 
1 week – 12 
months 
12 weeks – 
6 months 
12 weeks – 
12 months 
6 months – 
12 months 
1 (mobility) 0.002 0.134 0.043 0.288 0.713 0.331 
2 (selfcare) 0.764 1.000 0.327 0.657 0.327 0.331 
3 (activity) 0.000 0.010 0.185 0.442 0.327 1.000 
4 (pain/ 
discomfort) 0.000 0.114 0.327 1.000 1.000 1.000 
5 (anxiety/ 
depression) 0.251 0.374 0.574 0.251 0.490 0.429 
6 (health/ 
status) 0.000 0.000 0.130 0.482 0.760 0.314 
Table 2d Female mean score P values for EQ-5D-3L (shaded indicates significant) 
Question 1-12 weeks  1 week – 6 
months 
1 week – 12 
months 
12 weeks – 
6 months 
12 weeks – 
12 months 
6 months – 
12 months 
1 (mobility) 0.001 0.656 0.744 0.207 0.712 0.327 
2 (selfcare) 1.000 1.000 0.325 1.000 0.325 0.327 
3 (activity) 0.000 0.002 0.292 0.566 1.000 0.664 
4 (pain/ 
discomfort) 0.000 0.005 0.202 0.740 0.161 1.000 
5 (anxiety/ 
depression) 0.002 0.010 0.169 0.145 0.254 0.574 
6 (health/ 
status) 0.000 0.000 0.003 0.931 0.409 0.504 
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Table 3a Patients referred for obesity mean NZPAQ P values (shaded indicates significant) 
Question 1-12 weeks  1 week – 6 
months 
1 week – 12 
months 
12 weeks – 
6 months 
12 weeks – 
12 months 
6 months – 
12 months 
1 (days) 0.000 0.000 0.017 0.379 0.812 0.864 
2 (mins) 0.722 0.734 0.739 0.446 0.554 0.840 
3 (days) 0.000 0.000 0.250 0.806 0.228 0.013 
4 (mins) 0.091 0.049 0.518 0.515 0.972 0.667 
5 (days) 0.018 0.000 0.235 0.541 0.658 0.332 
6 (mins) 0.614 0.400 0.567 0.104 0.609 0.130 
7 (days) 0.000 0.000 0.492 0.626 0.108 0.087 
8 (1-5) 0.000 0.000 0.000 0.319 0.397 0.379 
Table 3b Patients referred for other reasons mean NZPAQ P values (shaded indicates significant) 
Question 1-12 weeks  1 week – 6 
months 
1 week – 12 
months 
12 weeks – 
6 months 
12 weeks – 
12 months 
6 months – 
12 months 
1 (days) 0.000 0.000 0.000 0.176 0.086 0.478 
2 (mins) 0.482 0.984 0.626 0.591 0.360 0.577 
3 (days) 0.000 0.000 0.001 0.728 0.472 0.344 
4 (mins) 0.367 0.723 0.173 0.740 0.036 0.062 
5 (days) 0.002 0.001 0.009 0.441 0.677 0.844 
6 (mins) 0.499 0.692 0.377 0.955 0.027 0.182 
7 (days) 0.000 0.000 0.000 0.370 0.787 0.810 
8 (1-5) 0.000 0.000 0.000 0.037 0.006 0.353 
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Table 3c EQ-5D-3L mean score P values for patients referred for obesity (shaded indicates 
significant) 
Question 1-12 weeks  1 week – 6 
months 
1 week – 12 
months 
12 weeks – 
6 months 
12 weeks – 
12 months 
6 months – 
12 months 
1 (mobility) 0.308 0.269 0.408 0.074 0.234 0.819 
2 (selfcare) 0.760 0.449 0.306 0.338 0.258 0.604 
3 (activity) 0.108 0.198 0.873 0.867 0.689 0.651 
4 (pain/ 
discomfort) 0.008 0.411 0.382 0.320 0.062 0.271 
5 (anxiety/ 
depression) 0.113 0.494 0.866 0.666 0.708 0.884 
6 (health/ 
status) 0.000 0.000 0.000 0.354 0.050 0.135 
Table 3d EQ-5D-3L mean score P values for patients referred for other reasons (shaded indicates 
significant) 
Question 1-12 weeks  1 week – 6 
months 
1 week – 12 
months 
12 weeks – 
6 months 
12 weeks – 
12 months 
6 months – 
12 months 
1 (mobility) 0.079 0.392 0.141 0.800 0.437 0.421 
2 (selfcare) 0.291 0.792 0.882 0.391 0.770 0.796 
3 (activity) 0.003 0.030 0.040 0.684 0.330 0.542 
4 (pain/ 
discomfort) 0.081 0.009 0.037 0.124 0.162 0.754 
5 (anxiety/ 
depression) 0.105 0.016 0.012 0.137 0.042 0.295 
6 (health/ 
status) 0.000 0.000 0.000 0.020 0.031 0.595 
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Table 4a Deprivation low v high mean score NZPAQ P values (shaded indicates significant) 
Question 1-12 weeks  1 week – 6 
months 
1 week – 12 
months 
12 weeks – 
6 months 
12 weeks – 
12 months 
6 months – 
12 months 
1 (days) 0.1148 0.0791 0.0426 0.1495 0.1148 0.0791 
2 (mins) 0.5576 0.0855 0.2875 0.0622 0.5576 0.0855 
3 (days) 0.9886 0.3855 0.9903 0.0452 0.9886 0.3855 
4 (mins) 0.7021 0.0444 0.2294 0.3175 0.7021 0.0444 
5 (days) 0.0279 0.1099 0.3430 0.9147 0.0279 0.1099 
6 (mins) 0.5464 0.8242 0.1777 0.6318 0.5464 0.8242 
7 (days) 0.0587 0.5403 0.5911 0.5964 0.0587 0.5403 
8 (1-5) 0.8542 0.4210 0.0090 0.0017 0.8542 0.4210 
Table 4b Deprivation low v high mean score EQ-5D-3L P values (shaded indicates significant) 
Question 1-12 weeks  1 week – 6 
months 
1 week – 12 
months 
12 weeks – 
6 months 
12 weeks – 
12 months 
6 months – 
12 months 
1 (mobility) 0.081 0.007 0.010 0.028 0.081 0.007 
2 (selfcare) 0.283 0.412 0.472 0.322 0.283 0.412 
3 (activity) 0.029 0.009 0.252 0.117 0.029 0.009 
4 (pain/ 
discomfort) 0.420 0.051 0.003 0.005 0.420 0.051 
5 (anxiety/ 
depression) 0.000 0.010 0.045 0.058 0.000 0.010 
6 (health/ 
status) 0.004 0.003 0.614 0.144 0.004 0.003 
 
